Document Detail

L-nucleoside enantiomers as antivirals drugs: a mini-review.
MedLine Citation:
PMID:  16797735     Owner:  NLM     Status:  MEDLINE    
The discovery that some nucleoside analogues endowed with the unnatural L-configuration can possess biological activities has been a significant breakthrough in antiviral chemotherapy. In this regard, lamivudine (3TC) was the first L-nucleoside enantiomer approved against HIV and HBV, and several other L-nucleosides are currently under clinical development as antiviral agents.
Christophe Mathé; Gilles Gosselin
Related Documents :
24816375 - Harm, tangible or feared: young victorians' adverse experiences from others' drinking o...
11737395 - Resistance and cross-resistance to abacavir.
9140265 - Human immunodeficiency virus type 1 protease inhibitors.
15629155 - Random mutagenesis of the b'a' core domain of yeast dna topoisomerase ii and large-scal...
12070355 - Barriers to drug discovery and development for alzheimer disease.
701845 - Greater promotion in sister chromatid exchanges by trimethylpsoralen than by 8-methoxyp...
Publication Detail:
Type:  Journal Article; Review     Date:  2006-05-23
Journal Detail:
Title:  Antiviral research     Volume:  71     ISSN:  0166-3542     ISO Abbreviation:  Antiviral Res.     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-21     Completed Date:  2006-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8109699     Medline TA:  Antiviral Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  276-81     Citation Subset:  IM    
Laboratoire de Chimie Organique Biomoléculaire de Synthèse, UMR 5625 CNRS, Université Montpellier II, Case Courrier 008, Place Eugène Bataillon, 34095 Montpellier, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / chemistry*,  pharmacology*
Cytomegalovirus / drug effects
Hepatitis B virus / drug effects
Nucleosides / chemistry*,  pharmacology*
Virus Diseases / virology
Viruses / drug effects
Reg. No./Substance:
0/Antiviral Agents; 0/Nucleosides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and ...
Next Document:  Brain and behavioural evidence for rest-activity cycles in Octopus vulgaris.